Marksans Pharma Limited has informed the Exchange about Audio Recording of investor(s) / analyst(s) meet Conference Call on Q4 FY26 Financial Results
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Marksans Pharma has notified the exchanges that the audio recording of its Q4 FY26 earnings conference call held on May 27, 2026 is now available on the company's website. This is a routine regulatory disclosure under SEBI listing requirements (Regulation 30). The filing itself does not contain any details about the actual discussion or financial results — it merely directs investors to the company's website to access the recording. The Q4 FY26 results were discussed during this call but the specifics are not included in this announcement.
This filing provides accessibility to the earnings call for investors who missed the live event. The stock impact will depend on what was actually discussed in the call, which is not disclosed in this announcement. Investors should listen to the recording for insights on Q4 performance and forward guidance.